CORONA Remedies Limited (CORONA) — Announcement | 30 June 2026(2 announcements)
CORONA Remedies announced the commercial start of operations at its EU-GMP approved women's hormone manufacturing facility in Ahmedabad, marking a key expansion in its pharma capabilities. The new plant, spanning 100,000 sq. ft., has an annual capacity of 194 million tablets/capsules and 1.5 million ointments/gels, boosting in-house hormone production by nearly 20%. The facility uses advanced closed-loop systems and real-time monitoring to ensure quality. This development strengthens the company's position in the growing women's healthcare market and supports both domestic and international demand for specialized hormone therapies.
CORONA Remedies announced the commercial launch of its EU-GMP approved women's hormone manufacturing facility in Ahmedabad, marking a major expansion in specialized pharma capacity. The new 1.0 lakh sq. ft. plant boosts in-house hormone production by nearly 20% with advanced closed-loop systems and a capacity of 194 million tablets/capsules annually. This facility strengthens India's pharma ecosystem and supports growing demand for hormonal therapies, particularly in fertility and menopause management.
About CORONA Remedies Limited (CORONA)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
📡 Get AI alerts when CORONA files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track CORONA — Free💡 Ask AI about this filing
📊 More CORONA filings
- 🔴 Financial Results — 3 August 2026 CORONA Remedies Limited announced that the audio recording of its Q1 FY27 earnings conference call f...
- 🔴 Financial Results — 22 July 2026 CORONA Remedies Limited announced its Q1 FY27 earnings conference call scheduled for August 3, 2026 ...
- 🟡 Board Meeting — 10 July 2026 CORONA Remedies Limited announced the e-voting results and Scrutinizer Report for its 22nd Annual Ge...
- 🟡 Board Meeting — 9 July 2026 CORONA Remedies held its 22nd Annual General Meeting on July 9, 2026 via video conference, approving...
- share transfer — 6 July 2026 CORONA Remedies Limited received a SEBI-mandated certificate confirming Regulation 74(5) does not ap...
🔥 Also filed on 30 June 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when CORONA files new disclosures
Track CORONA filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track CORONA — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research